Mary Jane Minkin, MD, discusses The Menopause Society 2023 Annual Meeting


Mary Jane Minkin, MD, FACOG, MSCP, discusses key takeaways from The Menopause Society 2023 Annual Meeting, held in Philadelphia, Pennsylvania from September 27-30.

Contemporary OB/GYN:

Can you explain your highlights or takeaways from The Menopause Society 2023 Annual Meeting?

Mary Jane Minkin, MD, FACOG, MSCP:

There are a lot of highlights from this meeting. Actually, for me, it may sound odd, but the highlight occurred pretty much early in the meeting, because we Susan Dominus as one of our keynote speakers, who wrote a, I think, landmark article in the Sunday, New York Times Magazine last February. The title was "Women Have Been Misled About Menopause," and that has really revolutionized, at least I think it has, women's interest and attitudes about menopause. I have had more calls this summer in the spring and summer than I ever have about menopausal topics. People are just really interested in it and women were really moved by this article, and she gave a fabulous talk. She got a standing ovation from the assembled multitudes in the audience and we've been chatting about it a lot, basically talking about the effect of transitions from estrogen and hormones for everybody to hormones to nobody after the Women's Health Initiative (WHI) with a resurgence of interest in them, and resurgence of education, we hope about hormonal therapy. So it's been a very interesting meeting that way, and a lot of other wonderful science as well.

Related Videos
Hot flashes poorly impact sleep quality | Image Credit:
What's new in endometrium care? | Image Credit:
How to manage bone health in midlife women | Image Credit: -
Highlights from The Menopause Society 2023 Annual Meeting  | Image Credit:
How fezolinetant changes management of hot flashes | Image Credit:
Fezolinetant effective against vasomotor symptoms | Image Credit:
Gloria Richard-Davis MD, MBA, NCMP, FACOG
Related Content
© 2023 MJH Life Sciences

All rights reserved.